Pictet Asset Management (UK)’s Achillion Pharmaceuticals ACHN Stock Holding History

Pictet Asset Management (UK)’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-277,000	Closed	-$2.42M	–	903
2015 Q1	$2.42M	Sell	277,000 -80,952	-23%	-$1.01M	0.01%	717
2014 Q4	$4.38M	Buy	+357,952	New	+$4.37M	0.02%	609
2013 Q4	–	Sell	-105,500	Closed	-$319K	–	889
2013 Q3	$319K	Hold	105,500	–	–	﹤0.01%	821
2013 Q2	$863K	Buy	+105,500	New	+$805K	﹤0.01%	779

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Pictet Asset Management (UK)'s ACHN Position: Q2 2015 in Review

Pictet Asset Management (UK) sold out of Achillion Pharmaceuticals (ACHN) in Q2 2015, closing a stake of 277,000 shares — an estimated $2.42M sold.

Pictet Asset Management (UK) first reported a position in ACHN in Q2 2013 and held it in 4 quarters. The position peaked at $4.38M in Q4 2014. 158 funds tracked by Wall St. Rank hold ACHN as of Q2 2015.

Pictet Asset Management (UK) reported no remaining Achillion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Pictet Asset Management (UK) sold 277,000 Achillion Pharmaceuticals shares in Q2 2015, an estimated $2.42M.
Pictet Asset Management (UK) first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Pictet Asset Management (UK)'s Achillion Pharmaceuticals position peaked at $4.38M in Q4 2014.
158 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2015, filed 13 Aug 2015.